Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReJoin vs Sodium Hyaluronate for Knee Osteoarthritis Cartilage Defects
NCT02855073Phase 2Unknown
- Sponsor
- AbelZeta
- Start
- Jul 2014
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogenic adipose tissue-derived mesenchymal progenitor cells in knee osteoarthritis (OA), Articular cartilage defect, sponsored by AbelZeta. Status: unknown.
02
Drugs
allogenic adipose tissue-derived mesenchymal progenitor cells
03
Conditions
knee osteoarthritis (OA)Articular cartilage defect
Beyond the preview
Go deeper on NCT02855073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855073.